AT476967T - STABLE PEGYLATED INTERFERON FORMULATION

24 members in 16 offices

This recordMember, by publication datePriority claim6 more offices are in the list below

Priority claims
Document	Office	Kind	Date
60084604	United States of America	P	2004-08-12
2005028441	United States of America	W	2005-08-11

Family members, oldest first
Document	Office	Kind
AU2005272862A1	Australia	A1	2006-02-23
CA2576549A1	Canada	A1	2006-02-23
WO2006020720A2	World Intellectual Property Organization (WIPO)	A2	2006-02-23
US2006051320A1	United States of America	A1	2006-03-09
WO2006020720A3	World Intellectual Property Organization (WIPO)	A3	2006-06-01
NO20071341L	Norway	L	2007-03-12
MX2007001663A	Mexico	A	2007-04-10
KR20070045244A	Republic of Korea	A	2007-05-02
EP1796647A2	European Patent Office (EPO)	A2	2007-06-20
CN101039660A	China	A	2007-09-19
HK1103977A	Hong Kong, China	A	2008-01-04
JP2008509919A	Japan	A	2008-04-03
BRPI0513332A	Brazil	A	2008-05-06
ZA200701154B	South Africa	B	2008-08-27
US7632491B2	United States of America	B2	2009-12-15
EP1796647B1	European Patent Office (EPO)	B1	2010-08-11
AT476967TThis record	Austria	T	2010-08-15
ATE476967T1	Austria	T1	2010-08-15
DE602005022895D1	Germany	D1	2010-09-23
CN101039660B	China	B	2010-10-06
ES2349472T3	Spain	T3	2011-01-03
CA2576549C	Canada	C	2011-01-18
AU2005272862B2	Australia	B2	2011-03-10
JP4971160B2	Japan	B2	2012-07-11

1 legal event, as the office reported them to INPADOC

Legal events, newest first
	Event	Code
2011-02-15	Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER	RER

CPC, 11: A61K31/7012
A61K38/21
A61K9/0019
A61K9/19
A61K38/212
A61K47/26
A61K47/60
A61P31/12
A61P35/00
A61P43/00
A61K47/50
Filled: the office’s first classification
IPC, 6: A61K38 21
A61K47 26
A61K47 48
A61K9 19
A61P31 12
A61P35 00

Stable pegylated interferon formulation